STUDY BASICS
Do you have a diabetic foot ulcer? You may be eligible for a research study to determine the role that biofilm infection plays in diabetic foot ulcer healing and recurrence. Compensation is provided.
STUDY PURPOSE
Diabetic foot ulcers (DFU) are one of the most common reasons for the hospitalization of diabetic patients and frequently results in amputation of lower limbs. Infection is a common complication of DFU. Biofilms are estimated to account for 60% of chronic wound infections. A biofilm can occur if a chronic infection causes bacteria to grow in a slime enclosed group. This grouping of bacteria is called a biofilm. Standard clinical tests to detect infection may not detect biofilm infection. Thus, biofilm infection may be viewed as a silent threat in wound care. The purpose of this study is to determine the role that biofilm infection plays in diabetic foot ulcer healing and recurrence.
COULD THIS STUDY BE RIGHT FOR YOU?
- Age 18 year or older
- Have an open diabetic foot ulcer
WHAT PARTICIPANTS CAN EXPECT
This study takes part in 2 phases. Participants will be followed for 16 weeks for wound closure (Phase A). Following this, participants may begin Phase B dependent upon wound closure. At this time, the wounds will be subject to Standard of Care (SoC) procedures followed by all wound clinicians.
IRB: 20202555
- Diabetic Foot Ulcer (DFU) Biofilm Infection and RecurrenceMEET THE RESEARCHER
Chandan Sen
Dr. Chandan K Sen (www.chandansen.org) is an Endowed University Professor and Director of the McGowan Institute for Regenerative Medicine and Associate Vice Chancellor for Life Science Innovation and Commercialization at the University of Pittsburgh. He serves as the Chief Scientific Officer, Wound Services, University of Pittsburgh Medical Center. Dr. Sen has been elected fellow of the National Academy of Inventors. Dr. Sen has published over 400 scientific reports and several books. His work has been cited in the literature over 52000 times with H-index of 116.